Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)?

Detalles Bibliográficos
Autores principales: Laster, Andrew J, Lam, Gordon K, Gladue, Heather S, Kashif, Ahmad A, Siceloff, Erin P, Lackey, Virginia D, Robertson, Cheryl R, Toci, Ashley L, Calabrese, Leonard H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086281/
https://www.ncbi.nlm.nih.gov/pubmed/35534054
http://dx.doi.org/10.1136/rmdopen-2022-002203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086281/
https://www.ncbi.nlm.nih.gov/pubmed/35534054
http://dx.doi.org/10.1136/rmdopen-2022-002203

Ejemplares similares